Moloney Securities Asset Management, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,009 filers reported holding NOVARTIS A G in Q1 2018. The put-call ratio across all filers is 0.56 and the average weighting 0.4%.

Quarter-by-quarter ownership
Moloney Securities Asset Management, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$260,252
-16.3%
2,555
-17.1%
0.05%
-14.5%
Q2 2023$311,106
-51.2%
3,083
-55.5%
0.06%
-53.8%
Q1 2023$637,836
-3.5%
6,933
-4.8%
0.12%
-18.5%
Q4 2022$660,714
+50.2%
7,283
+25.9%
0.15%
+36.4%
Q3 2022$440,000
-10.6%
5,783
-0.6%
0.11%
-7.0%
Q2 2022$492,000
-1.8%
5,818
+1.9%
0.12%
+18.6%
Q1 2022$501,000
-0.4%
5,707
-0.8%
0.10%
+14.1%
Q4 2021$503,000
-13.0%
5,752
-18.7%
0.08%
-19.0%
Q3 2021$578,000
-10.9%
7,071
-0.6%
0.10%
-11.0%
Q2 2021$649,000
-3.1%
7,113
-9.3%
0.12%
-10.6%
Q1 2021$670,000
-10.8%
7,843
-1.4%
0.13%
-21.0%
Q4 2020$751,000
-29.5%
7,953
-35.1%
0.17%
-40.6%
Q3 2020$1,066,000
-1.3%
12,253
-0.9%
0.28%
-10.5%
Q2 2020$1,080,000
+3.8%
12,368
-2.0%
0.31%
-15.8%
Q1 2020$1,040,000
-3.3%
12,618
+11.0%
0.37%
+12.3%
Q4 2019$1,076,000
+8.8%
11,367
-0.2%
0.33%
+0.6%
Q3 2019$989,000
+3.2%
11,386
+8.6%
0.33%
+3.1%
Q2 2019$958,000
-11.9%
10,486
-7.3%
0.32%
-14.9%
Q1 2019$1,088,000
+60.5%
11,317
+43.2%
0.38%
+35.7%
Q4 2018$678,000
+4.1%
7,905
+4.7%
0.28%
+22.6%
Q3 2018$651,000
+14.6%
7,553
+0.5%
0.23%
+4.6%
Q2 2018$568,000
-31.9%
7,516
-27.2%
0.22%
-36.1%
Q1 2018$834,000
+117.8%
10,319
+126.1%
0.34%
+109.9%
Q4 2017$383,000
+55.1%
4,564
+58.7%
0.16%
+46.4%
Q3 2017$247,0002,8760.11%
Other shareholders
NOVARTIS A G shareholders Q1 2018
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders